Trial intelligence / Profile preview

Peritoneal bupivacaine for pain after pediatric laparoscopic appendicectomy

ACTRN12613001159741Phase 4Completed

Sponsor
The University of Auckland
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of bupivacaine in acute appendicitis (2 arms), sponsored by The University of Auckland. Primary endpoints: Global pain scores and Localized postoperative pain. Started May 2014; status: completed.

02

Drugs

bupivacaine
03

Conditions

acute appendicitis

Beyond the preview

Go deeper on ACTRN12613001159741.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613001159741.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call